FDA approves GSK's drug for skin infection

The FDA approved GlaxoSmithKline's Altabax for treating the skin infection impetigo, caused by the staphylococcus and streptococcus bacteria. The drug is the first in a new class of prescription tropical antibacterial to be approved by FDA in almost 20 years. GSK also is seeking European approval of Altabax.

View Full Article in:

Independent (London) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Clara, CA
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA